list all glp 1 drugs GLP-1 Drug Comparison in Diabetes and Obesity Treatment Every GLP-1 and incretin drug

Peptide GLP-1 agonists activate both Gs-cAMP and beta-arrestin pathways, with relative bias varying among different agonists

Early studies and reviews suggest GLP-1 medications may reduce binge episodes in some individuals by reducing cravings and reward-driven eating

[DOI] [PubMed] [Google Scholar] [122].Pratley RE, Nauck MA, Barnett AH, Feinglos MN, Ovalle F, Harman-Boehm I, Ye J, Scott R, Johnson S, Stewart M, Rosenstock J, H.s

They reduce de novo lipogenesis by inhibiting transcription factor sterol regulatory element-binding protein 1c (SREBP-1c), which is a master regulator of fatty acid synthesis ( TABLE 1 Therapeutic actions of GLP-1 receptor agonists in liver disease: summary of experimental and clinical findings

For AD specifically, given the well-established effects of GLP-1 RAs on tau hyperphosphorylation, we recommend that future GLP-1 RA clinical trials focus on the tau-positive subgroup of patients

High-fiber diets may modestly increase endogenous GLP-1 secretion, though effects are minimal compared to medications